C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS-Reference-Cited by-同舟云学术

C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS

Published:2014-10 Issue: Volume:1584 Page:59-72
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Hatzipetros Theo,Bogdanik Laurent P.,Tassinari Valerie R.,Kidd Joshua D.,Moreno Andy J.,Davis Crystal,Osborne Melissa,Austin Andrew,Vieira Fernando G.,Lutz Cathleen,Perrin Steve

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference35 articles.

1. ALS drug development: reflections from the past and a way forward;Aggarwal;Neurotherapeutics,2008

2. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome;Alves;Brain Res.,2011

3. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis;Arai;Biochem. Biophys. Res. Commun.,2006

4. Genetic affinities of inbred mouse strains of uncertain origin;Atchley;Mol. Biol. Evol.,1993

5. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis;Barbeito;Brain Res. Rev.,2004

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory pathology in the TDP-43 transgenic mouse model of amyotrophic lateral sclerosis;Frontiers in Physiology;2024-08-27

2. Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis;Nature Reviews Neurology;2024-07-04

3. Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice;Gut Microbes;2024-06-11

4. Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS;International Journal of Molecular Sciences;2024-02-03

5. Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis;Aging and disease;2024